SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-18-017280
Filing Date
2018-06-19
Accepted
2018-06-19 21:39:13
Documents
2
Period of Report
2018-06-19

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1555
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 4448
  Complete submission text file 0000899243-18-017280.txt   7377
Mailing Address C/O NEKTAR THERAPEUTICS 201 INDUSTRIAL ROAD SAN CARLOS CA 94070
Business Address
Huh Hoyoung (Reporting) CIK: 0001401267 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38533 | Film No.: 18908554

Mailing Address 101 MONTGOMERY STREET, SUITE 2550 SAN FRANCISCO CA 94104
Business Address 101 MONTGOMERY STREET, SUITE 2550 SAN FRANCISCO CA 94104 650-391-9740
Eidos Therapeutics, Inc. (Issuer) CIK: 0001731831 (see all company filings)

IRS No.: 463733671 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations